The Discounted Cash Flow (DCF) valuation of Neuropace Inc (NPCE) is (10.10) USD. With the latest stock price at 12.84 USD, the upside of Neuropace Inc based on DCF is -178.7%.
Based on the latest price of 12.84 USD and our DCF valuation, Neuropace Inc (NPCE) is a sell. selling NPCE stocks now will result in a potential gain of 178.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.3% - 9.6% | 8.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (17.90) - (7.40) | (10.10) |
| Upside | -239.4% - -157.6% | -178.7% |